Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 1034

2'-fucosyllactose

Intended Use: Intended for use as an ingredient in exempt hypoallergenic extensively hydrolyzed cow milk or goat milk protein- and amino acid-based infant formula for term infants with cow milk protein allergy at a level of 2.4 g/L infant formula as consumed.
Basis: Scientific procedures
Notifier: Glycom A/S
Notifier Address: Kogle Allé 4
2970 Hørsholm
Denmark
GRAS Notice (releasable information): GRN 1034 with amendments (in PDF) (3 MB)
Date of closure: Oct 21, 2022
FDA's Letter: FDA has no questions (in PDF) (258 kB)
-
-